Stablelab Competitors

LabConnect is a global central laboratory services and clinical trial sample solutions partner, integrating and optimizing sample-related activities across the study lifecycle with scientific, operational, consulting, and embedded resourcing expertise.

Join us at SynergyLabs® in our pursuit of innovation! As a concept-to-shelf American manufacturer, we produce over 150 branded and private-label products sold in pet specialty, veterinary, grocery, mass merchandisers, and big-box stores across 65 countries worldwide. Our chemistry and research and development experts lead the way in scientific and innovative products for dogs and cats, including nutritional supplements, grooming, health, and veterinary items. For 6 consecutive years, Inc 5000 has recognized SynergyLabs as one of America's Fastest-Growing Privately Held Companies. Our dedication to growing healthy, active, and happy pets (and their parents!) is at the heart of everything we do. Join us in our mission to innovate and improve the lives of pets worldwide.

In 2022, TECHLAB was acquired by SSI Diagnostica Group. Today, TECHLAB functions as a brand under SSI Diagnostica Group. About SSI Diagnostica Group: SSI Diagnostica Group is a global in vitro diagnostics (IVD) company, specializing in infectious disease diagnostics. We employ staff and operate offices in Denmark, the United States, and China, with a total of eleven sites across three different continents. Each year, we deliver diagnostic solutions in more than 130 countries and manufacture more than 60 million diagnostic tests – helping people receive the right diagnosis and, ultimately, the right treatment as quickly as possible. Operating as one company today, SSI Diagnostica Group is historically the result of a series of acquisitions: SSI Diagnostica (2016), CTK Biotech (2020), Beijing Genesee Biotech (2020), Techlab (2022), Gulf Coast Scientific (2025), and InDevR (2026). Each brand has brought unique expertise and experience to the group, and as a combined company we offer more than 200 years of combined scientific expertise. SSID Group’s mission is to empower healthcare professionals to prevent, monitor, and diagnose infectious diseases – enabling better treatment outcomes for patients worldwide. SSI Diagnostica group has four disease focus areas: Gastric, Respiratory, Bloodborne, and general microbiology.